Association of the TNFRSF1B-rs1061622 variant with nonresponse to infliximab in ulcerative colitis.

Sci Rep · 2025 · PMC12104363 · PMID 40414945

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

close to significancep-value = 0.055so close (0.05 < p ≤ 0.1)

For the first biologic taken, the association was close to significance level (p-value = 0.055).

also in 514 other papers

showed a trendno p-value reported

also showed a trend towards a higher likelihood to be a NR for adalimumab compared to infliximab 22 .

also in 15,197 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.